# GlobeStar Therapeutics Corp

GlobeStar Therapeutics Corp is a company headquartered in Richland, WA, United States.

## Company overview

- **Legal name:** GlobeStar Therapeutics Corp
- **Former names in filing history:** AngioSoma, Inc. (2016-06-22 to 2021-05-21); First Titan Corp. (2010-11-03 to 2016-06-16)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Richland, WA, United States
- **Incorporated in:** WY
- **Fiscal year end:** September 30
- **SEC CIK:** 0001502152

## About

GlobeStar Therapeutics Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001502152, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-01-19, it reported net income of USD -1,949,249 for the fiscal period ended 2023-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-09-30)

- **Net income:** -$1.9M (USD -1,949,249)
- **Operating cash flow:** -$205,760 (USD -205,760)

### FY2022 (period ended 2022-09-30)

- **Net income:** -$1.5M (USD -1,487,810)
- **Total assets:** $9,915 (USD 9,915)
- **Cash and equivalents:** $6,365 (USD 6,365)
- **Operating cash flow:** -$326,995 (USD -326,995)

### FY2021 (period ended 2021-09-30)

- **Net income:** -$9.8M (USD -9,801,628)
- **Total assets:** $5,960 (USD 5,960)
- **Cash and equivalents:** $5,960 (USD 5,960)
- **Operating cash flow:** -$751,232 (USD -751,232)

### FY2020 (period ended 2020-09-30)

- **Revenue:** $77 (USD 77)
- **Net income:** -$541,731 (USD -541,731)
- **Total assets:** $89,912 (USD 89,912)
- **Cash and equivalents:** $81,442 (USD 81,442)
- **Operating cash flow:** -$239,735 (USD -239,735)

## Recent SEC filings

- Form 8-K — filed 2024-10-28 — period 2024-08-08 — FORM 8-K CURRENT REPORT FOR 08-08-2024
- Form 10-Q — filed 2024-10-11 — period 2024-06-30 — FORM 10-Q QUARTERLY REPORT FOR 06-30-2024
- Form 10-Q — filed 2024-06-28 — period 2024-03-31 — FORM 10-Q QUARTERLY REPORT FOR 03-31-2024
- Form 10-Q — filed 2024-03-12 — period 2023-12-31 — FORM 10-Q QUARTERLY REPORT FOR 12-31-2023
- Form 10-K — filed 2024-01-19 — period 2023-09-30 — FORM 10-K ANNUAL REPORT FOR 09-30-2023
- Form 8-K — filed 2023-11-13 — period 2023-09-26 — FORM 8-K CURRENT REPORT FOR 09-26-2023
- Form 10-Q — filed 2023-08-17 — period 2023-06-30 — FORM 10-Q QUARTERLY REPORT FOR 06-30-2023
- Form 8-K — filed 2023-06-27 — period 2023-06-27 — FORM 8-K CURRENT REPORT FOR 06-27-2023
- Form 8-K — filed 2023-06-22 — period 2023-06-21 — FORM 8-K CURRENT REPORT FOR 06-21-2023
- Form 10-Q — filed 2023-05-31 — period 2023-03-31 — FORM 10-Q QUARTERLY REPORT FOR 03-31-2023
- Form 8-K — filed 2023-04-06 — period 2023-04-04 — FORM 8-K CURRENT REPORT FOR 04-04-2023
- Form 10-Q — filed 2023-02-13 — period 2022-12-31 — FORM 10-Q QUARTERLY REPORT FOR 12-31-2022

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/globestar-therapeutics-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology